The unique properties of nanomaterials allow these materials to be used in applications unavailable to other forms of a substance. Nanotechnology has been declared a key technology for the European Union with thousands of nano-enabled products on the market in the EU. Nanomaterials are defined by their size, with at least one dimension lying in the range of 1nm to 100nm. On this scale the surface area to volume ratio increases dramatically, with a much greater proportion of its atoms being found at the surface than in larger particles, changing its physical and chemical properties.
Nanomaterials and associated technologies have received attention from many sectors of industry, such as:
The same properties that have driven this technological revolution have led to concerns over the potential health risks from these substances. There is evidence that nanoforms of some substances demonstrate different toxicokinetic and toxicological profiles to their bulk analogues. This has resulted in a reluctance by some industries to fully exploit the potential benefits of this novel technology. Much work has been focused on understanding the biological and environmental behaviour of these substances to clarify the risks of nanotechnology, but it is still in its infancy with most work concentrating on short-term and mechanistic studies.
Yordas Group has played an active role in a number of EU funded projects delivering a range of novel tools designed to identify and control risks from nanomaterials, including
We are able to help by checking that the nanomaterials contained within company’s products comply with any current legislations so that they can be successfully sold on the market.
How we can help